Bausch + Lomb has bought the assets and U.S. rights...

Bausch + Lomb has bought the assets and U.S. rights for Zirgan from Sirion Therapeutics. Zirgan is a topical anti-viral used to treat acute herpetic keratitis, or corneal ulcers, a condition that often results in corneal transplants. It is caused by the herpes simplex virus, and recurs repeatedly, leading to ...

Already an Eyewear Intelligence subscriber? Sign in here.

barrier_image_OIC

Subscribe today

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation
  • Organisation-wide access across offices, people and devices

To continue reading this article register now.